ArticleDrug design, development and therapy2020

Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model.

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.